Locations
United States · Philadelphia, PA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2015
Excision Bio Therapeutics is a biotechnology company focused on developing CRISPR-based therapies to cure viral infectious diseases. Founded in 2015, the company leverages proprietary gene-editing technology to excise viral genomes from infected individuals, aiming to improve the lives of chronically ill patients. Their pipeline includes therapies targeting HIV, herpes simplex viruses, and Hepatitis B, addressing significant unmet medical needs in large patient populations. Excision's innovative approach has already demonstrated functional therapeutic treatments for HIV in animal models, positioning the company as a leader in the gene-editing space with extensive intellectual property and partnerships with leading research institutions.
Something looks off?